Cargando…

Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening

The first biomarker-based cervical cancer screening test, p16/Ki-67 dual-stained cytology (DS), has been clinically validated and approved in the United States for triage of women being screened for cervical cancer who test positive for high-risk human papillomavirus (hrHPV). The primary aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harper, Diane M., Anderson, Rye J., Baker, Ed, Yu, Tiffany M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320467/ https://www.ncbi.nlm.nih.gov/pubmed/37210751 http://dx.doi.org/10.1158/1940-6207.CAPR-22-0455

Ejemplares similares

Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki‐67 dual‐stained cytology—Retrospective insights from ATHENA
por: Stoler, Mark H., et al.
Publicado: (2019)

Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing
por: Kocken, M, et al.
Publicado: (2012)

Significance of Triple Detection of p16/ki-67 Dual-Staining, Liquid-Based Cytology and HR HPV Testing in Screening of Cervical Cancer: A Retrospective Study
por: Yu, Li, et al.
Publicado: (2022)

Application of p16/Ki-67 dual-staining cytology in cervical cancers
por: Yu, Li, et al.
Publicado: (2019)

Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology‐screened referral population
por: Leeman, Annemiek, et al.
Publicado: (2018)

hrHPV E5 oncoprotein: immune evasion and related immunotherapies
por: de Freitas, Antonio Carlos, et al.
Publicado: (2017)

Longitudinal analysis on the ecological dynamics of the cervicovaginal microbiome in hrHPV infection
por: Molina, Mariano A., et al.
Publicado: (2023)

Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and Uninfected Rwandan women: implications for hrHPV-based screening in Rwanda
por: Sinayobye, Jean d’Amour, et al.
Publicado: (2014)

Preferences and Experiences Regarding the Use of the Self-Sampling Device in hrHPV Screening for Cervical Cancer
por: Dieleman, Marjolein, et al.
Publicado: (2021)

High-risk Human Papillomavirus (hrHPV) Prevalence and Genotype Distribution among Turkish Women
por: Gecer, Melin
Publicado: (2023)

LINE-1 and Alu Methylation in hrHPV-Associated Precancerous Cervical Samples
por: Chaiwongkot, Arkom, et al.
Publicado: (2022)

Clinical validation of p16/Ki‐67 dual‐stained cytology triage of HPV‐positive women: Results from the IMPACT trial
por: Wright, Thomas C., et al.
Publicado: (2021)

Distinct Patterns of Myeloid Cell Infiltration in Patients With hrHPV-Positive and hrHPV-Negative Penile Squamous Cell Carcinoma: The Importance of Assessing Myeloid Cell Densities Within the Spatial Context of the Tumor
por: Rafael, Tynisha S., et al.
Publicado: (2021)

Assessing the Cervicovaginal Microbiota in the Context of hrHPV Infections: Temporal Dynamics and Therapeutic Strategies
por: Molina, Mariano A., et al.
Publicado: (2022)

p16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening
por: Han, Qin, et al.
Publicado: (2020)

Triage Strategies for Non-16/Non-18 HPV-Positive Women in Primary HPV-Based Cervical Cancer Screening: p16/Ki67 Dual Stain vs. Cytology
por: Mazurec, Karolina, et al.
Publicado: (2023)

Evaluation of p16/Ki-67 Dual Staining Compared with HPV Genotyping in Anal Cytology with Diagnosis of ASC-US for Detection of High-Grade Anal Intraepithelial Lesions
por: Pichon, Maxime, et al.
Publicado: (2019)

Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays
por: Dippmann, Carolin, et al.
Publicado: (2020)

HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: a prospective study
por: Andersen, Berit, et al.
Publicado: (2020)

Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study
por: Ikenberg, Hans, et al.
Publicado: (2013)

In-depth insights into cervicovaginal microbial communities and hrHPV infections using high-resolution microbiome profiling
por: Molina, Mariano A., et al.
Publicado: (2022)

Evaluation of the impacts of photodynamic therapy on the prognosis of patients with hrHPV infection based on BTNL8 expression
por: Lv, Hongqing, et al.
Publicado: (2023)

Frequency of Chlamydia trachomatis infection in cervical intraepithelial lesions and the status of cytological p16/Ki-67 dual-staining
por: Robial, R., et al.
Publicado: (2017)

Liquid-Based Screening Tests Results: HPV, Liquid-Based Cytology, and P16/Ki67 Dual-Staining in Private-Based Opportunistic Cervical Cancer Screening
por: Trzeszcz, Martyna, et al.
Publicado: (2021)

DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women
por: Boers, A, et al.
Publicado: (2014)

Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study
por: Uijterwaal, M H, et al.
Publicado: (2014)

p16(INK4a)/Ki-67 dual stain cytology for cervical cancer screening in Thika district, Kenya
por: Ngugi, Caroline Wangari, et al.
Publicado: (2015)

Human Papillomavirus Detection and Abnormal Anal Cytology in HIV-infected Patients Using p16/Ki-67 Dual-Staining
por: Patarapadungkit, Natcha, et al.
Publicado: (2020)

The Role of p16/Ki67 Dual Staining in Cervical Cancer Screening
por: Dovnik, Andraž, et al.
Publicado: (2023)

Prevalence and Characteristics of hrHPV Infection among 414,540 Women: A Multicenter Study in Central and Eastern China
por: Wang, Yi, et al.
Publicado: (2019)

Implementation of p16/Ki67 dual stain cytology in a Danish routine screening laboratory: Importance of adequate training and experience
por: Hammer, Anne, et al.
Publicado: (2020)

Novel concepts in cervical cancer screening: a comparison of VIA, HPV DNA test and p16(INK4a)/Ki-67 dual stain cytology in Western Kenya
por: Orang’o, Elkanah Omenge, et al.
Publicado: (2020)

Triaging HPV-Positive Cervical Samples with p16 and Ki-67 Dual Stained Cytology within an Organized Screening Program—A Prospective Observational Study from Western Norway
por: Øvestad, Irene Tveiterås, et al.
Publicado: (2023)

Vaginal microbiota diversity and paucity of Lactobacillus species are associated with persistent hrHPV infection in HIV negative but not in HIV positive women
por: Dareng, Eileen O., et al.
Publicado: (2020)

Targeted RNA next generation sequencing analysis of cervical smears can predict the presence of hrHPV-induced cervical lesions
por: Andralojc, Karolina M., et al.
Publicado: (2022)

Evaluation of the Training Program for p16/ Ki-67 Dual Immunocytochemical Staining Interpretation for Laboratory Staff Without Experience in Cervical Cytology and Immunocytochemistry
por: Prevodnik, Veronika Kloboves, et al.
Publicado: (2020)

HPV Genotype Specific and Age Stratified Immediate Prevalence of Cervical Precancers and Cancers in Women with NILM/hrHPV+: A Single Center Retrospective Study of 26,228 Cases
por: Liu, Qin, et al.
Publicado: (2021)

Type-specific Distribution of Cervical hrHPV Infection and the Association with Cytological and Histological Results in a Large Population-based Cervical Cancer Screening Program: Baseline and 3-year Longitudinal Data
por: Song, Fangbin, et al.
Publicado: (2020)

A comparative analysis of cycle threshold (Ct) values from Cobas4800 and AmpFire HPV assay for triage of women with positive hrHPV results
por: Zhang, Yi, et al.
Publicado: (2023)

Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease
por: Babion, Iris, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b7jean2ivbe71uotmtj03safhl